Johnson and Johnson Ovarian Cancer Class Action

Merchant Law Group LLP has launched Canada-wide class action litigation against Johnson & Johnson seeking compensation for Canadian residents who have experienced ovarian cancer as a result of using J&J baby powder products (also known as talc products).

Ovarian cancer is developed by the abnormal or uncontrollable growth of ovarian cells which lead to malignant tumours causing cancer. Most of these cancers effect the epithelial cells covering the lining of the fallopian tube or ovary.

Unfortunately, for many Canadian women prolonged use of Johnson and Johnson baby products containing “baby powder” has been scientifically linked to an increased risk of developing epithelial ovarian cancer. Baby powder, also known as talcum powder, is made from talc, which consists mainly of magnesium, silicon, and oxygen.

Baby powder is commonly used to prevent moisture and reduce friction in sensitive areas on both adults and children. Studies have shown that the prolonged use of products containing talcum powder can increase ones risk of developing ovarian cancer, particularly in instances where it is used regularly on a woman’s genital area. Over time, the use of baby powder on a woman’s genital area, whether it be applied to a woman’s underwear, tampons, sanitary napkins, or otherwise, is alleged to increase a woman’s risk of developing ovarian cancer.

An estimated 3,000 Canadian women will be diagnosed with this cancer every year. An estimated 1,950 will die from it.

A Missouri trial jury ordered Johnson & Johnson to pay $72 million in damages to the family of a woman whose death from ovarian cancer was linked to her use of talc based baby powder for several decades. Jurors found the company liable for fraud, negligence and conspiracy, for their failure to warn consumers about the increased risk of cancer by use of their products. It is believed that Johnson & Johnson has known about these risks since the 1980s.